Skip to main content
Longevity Science· 4 min read· in Health

Scientists Identify Protein That Mimics Calorie Restriction's Anti-Aging Effects, Opening Door to New Longevity Drugs

Yale researchers have discovered that a moderate reduction in calories lowers an immune protein called C3, cooling age-related inflammation. Blocking this protein in mice perfectly mimicked the longevity benefits of fasting, paving the way for new anti-aging therapies.

By Pedro Almeida

Most people want to live longer, healthier lives, but very few are willing to endure the permanent hunger of severe calorie restriction. For decades, science has presented a frustrating trade-off: eat significantly less to slow the biological clock, but suffer through feeling cold, tired, and hungry, while risking weakened immunity and stunted growth.[3][4]

Now, researchers may have found a way to bypass the hunger entirely. A landmark study published in Nature Aging by scientists at the Yale School of Medicine has identified a specific immune protein that acts as a master switch for the anti-aging benefits of a low-calorie diet.[1][5]

The protein, known as complement component 3 (C3), normally helps the body fight off infections. But as humans age, C3 levels rise and begin to drive chronic, low-grade inflammation—a destructive process scientists call "inflammaging," which accelerates age-related diseases and cellular decline.[1][3]

The discovery stems from the CALERIE trial, a rigorous two-year National Institutes of Health study. In this trial, healthy adults successfully reduced their daily calorie intake by 11 to 14 percent—a moderate reduction equivalent to skipping a large daily snack, rather than enduring a starvation diet.[5][6]

Participants in the CALERIE trial achieved significant reductions in the inflammatory C3 protein through moderate portion control.

By analyzing plasma samples from 42 participants, the Yale team tracked over 7,000 different proteins over the two-year period. They found that C3 levels plummeted in the individuals who maintained the moderate calorie restriction, effectively cooling off the body's inflammatory response.[1][7]

Surprisingly, the drop in C3 wasn't coming from the liver, where the protein is typically produced. Instead, single-cell RNA sequencing revealed that the reduction was driven by white adipose tissue—specifically, aging immune cells called macrophages residing within body fat.[1][2]

Even more encouraging for the general public: the anti-aging effect was not tied to how much weight the participants lost. While most individuals lost about 18 pounds, the reduction in C3 occurred independently of the number on the scale, suggesting the biological benefits of eating slightly less are metabolic, not just cosmetic.[3][5]

To prove C3 was the actual molecular switch, the researchers turned to animal models. When they used a targeted drug to block C3 activation in mice, the animals experienced a dramatic reduction in age-related inflammation, perfectly mimicking the benefits of calorie restriction without the mice having to diet at all.[1][4]

C3 protein levels naturally rise with age, driving chronic inflammation, but calorie restriction helps maintain youthful baselines.

This finding perfectly illustrates a biological concept called antagonistic pleiotropy. As lead author Dr. Vishwa Deep Dixit explains, biological mechanisms that are essential for survival early in life—like a robust C3 immune response to fight childhood infections—can become detrimental later in life, driving the inflammation that causes aging.[3][4]

This is a crucial breakthrough because severe calorie restriction—cutting 30 to 40 percent of calories—carries severe costs. In animal models, extreme restriction weakens the immune system, impairs growth, and reduces reproductive success, making it a dangerous strategy for humans to attempt on their own.[4][6]

By identifying C3 as the specific target, the door is now open for pharmacological interventions. Researchers are already exploring whether existing, FDA-approved drugs that inhibit C3 could be repurposed to safely slow aging and extend healthspan in humans.[3][5]

Researchers traced the age-related rise in C3 to macrophages residing within white adipose tissue.

While a "longevity pill" targeting C3 is still years away from pharmacy shelves, the current takeaway is highly practical. The study proves that you do not need to starve yourself to reap profound anti-aging benefits.[5][6]

A modest 11 to 14 percent reduction in calories is highly achievable for most adults without feeling deprived. This small shift is enough to lower C3 levels, calm systemic inflammation, and strengthen immune defenses without the risks of extreme dieting.[3][5]

By analyzing over 7,000 proteins in human plasma, researchers pinpointed C3 as the master switch for calorie restriction's benefits.

However, researchers caution against trying to suppress the immune system with unproven supplements. C3 remains a vital part of the body's defense against pathogens. The goal of future therapies will be to restore the balance of C3 to youthful levels, not to eliminate it entirely.[1][3]

Where opinion splits

Longevity Researchers

Scientists focused on extending human healthspan see C3 as a prime pharmacological target.

For longevity researchers, the identification of C3 is a major milestone because it separates the metabolic benefits of calorie restriction from the behavioral challenge of dieting. Since long-term compliance with strict diets is notoriously poor, developing a drug that safely inhibits C3 could deliver the anti-aging and anti-inflammatory benefits of fasting to the general population, without requiring extreme lifestyle changes.

Immunologists

Immune system experts caution that C3 is a vital defense mechanism that cannot simply be turned off.

Immunologists emphasize the concept of antagonistic pleiotropy—the idea that C3 evolved to protect humans from lethal infections early in life. While it may drive 'inflammaging' in our later years, completely blocking C3 could leave older adults vulnerable to pathogens. Therefore, they argue that any future longevity drug must carefully modulate C3 back to youthful baseline levels, rather than neutralizing it entirely.

Public Health Advocates

Health advocates focus on the immediate, practical takeaway of moderate portion control.

Public health experts view the CALERIE trial results as highly encouraging because an 11 to 14 percent reduction in calories is sustainable. Rather than waiting decades for a C3-inhibiting drug to clear FDA trials, they argue that adults can achieve these exact anti-aging benefits today by making minor dietary adjustments, such as eliminating a single daily snack or slightly reducing portion sizes, without experiencing the misery of severe restriction.

Key points

  1. Yale researchers identified an immune protein, C3, that drives age-related inflammation when elevated.
  2. A moderate 11 to 14 percent reduction in calories significantly lowered C3 levels in human trials.
  3. The anti-aging benefits occurred independently of how much weight the participants lost.
  4. Blocking C3 in mice perfectly mimicked the longevity benefits of calorie restriction without dieting.

Unanswered questions

  • It remains unclear exactly how long a person must maintain a moderate calorie restriction to see a permanent reduction in C3 levels.
  • Researchers do not yet know if existing FDA-approved C3 inhibitors can be safely repurposed for long-term anti-aging use in humans.
  • The precise mechanism by which white adipose tissue signals macrophages to increase C3 production with age is still being investigated.

How we got here

  1. 1935

    Early scientific studies first demonstrate that severe calorie restriction extends the lifespan of rodents.

  2. 1952

    Biologist Peter Medawar proposes the theory of 'antagonistic pleiotropy' to explain how early-life survival traits cause aging.

  3. 2024

    The NIH-funded CALERIE trial concludes, proving that a moderate 14 percent calorie reduction is safe and sustainable for humans.

  4. April 2026

    Yale researchers publish findings in Nature Aging identifying the C3 protein as the molecular switch for calorie restriction's benefits.

Longevity Researchers 40%Immunologists 30%Public Health Advocates 30%
Longevity Researchers
Focus on developing pharmacological interventions that mimic fasting to extend human healthspan.
Immunologists
Emphasize the need to balance anti-aging interventions with maintaining robust immune defenses against infections.
Public Health Advocates
Highlight the immediate accessibility of moderate, sustainable calorie reduction over waiting for future drugs.

Perspectives this story doesn't cover

  • Dietitians and Nutritionists
  • Patients with Autoimmune Disorders

Sources

Source coverage

7 outlets

3 viewpoints surfaced

Longevity Researchers 40%Immunologists 30%Public Health Advocates 30%
  1. [1]Nature AgingLongevity Researchers

    Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging

    Read on Nature Aging →
  2. [2]bioRxivLongevity Researchers

    Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging

    Read on bioRxiv →
  3. [3]SciTechDailyLongevity Researchers

    Scientists Identify Immune Protein That Could Mimic Anti-Aging Effects of Calorie Restriction

    Read on SciTechDaily →
  4. [4]ScienceDailyLongevity Researchers

    One Protein Could Mimic Calorie Restriction

    Read on ScienceDaily →
  5. [5]Yale NewsImmunologists

    Cutting Calories to Slow Aging—Without Compromising Health

    Read on Yale News →
  6. [6]MedicalXpressImmunologists

    Cutting calories to slow aging—without compromising health

    Read on MedicalXpress →
  7. [7]OncoDailyPublic Health Advocates

    Scientists Identify Immune Protein That Could Mimic Anti-Aging Effects of Calorie Restriction

    Read on OncoDaily →

Comments

Stay informed

Every angle. Every day.

Get Health stories with full source coverage and perspective breakdowns, free every day.